Immunotherapy Following High-Dose Chemotherapy Improves Prognosis Of Acute Myeloid Leukaemia
Patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer, benefited from high-dose cytarabine followed by immunotherapy treatment with pembrolizumab, according to … Read more








